Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients. [electronic resource]
Producer: 20181113Description: 590-595 p. digitalISSN:- 1879-355X
- Administration, Topical
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- administration & dosage
- Cetuximab -- administration & dosage
- Dermatologic Agents -- administration & dosage
- Dose Fractionation, Radiation
- Female
- Glycosaminoglycans -- administration & dosage
- Head and Neck Neoplasms -- radiotherapy
- Humans
- Male
- Middle Aged
- Protective Agents -- administration & dosage
- Radiation-Protective Agents -- administration & dosage
- Radiodermatitis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.